Results 21 to 30 of about 258,064 (337)

ENDOSCOPIC AND HISTOPATHOLOGIC GASTRIC CHANGES IN CHRONIC USERS OF PROTON-PUMP INHIBITORS

Arquivos de Gastroenterologia, 2015
Background Proton-pump inhibitors have been used for at least two decades. They are among the most commonly sold drugs in the world. However, some controversy remains about the indications for their use and the consequences of their prolonged use ...
Sílvia Maria Perrone CAMILO, Élia Cláudia de Souza ALMEIDA, Benito André Silveira MIRANZI, Juliano Carvalho SILVA, Rosemary Simões NOMELINI, Renata Margarida ETCHEBEHERE   +5 more
doaj   +1 more source

Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors

eJHaem, 2020
Background Iron deficiency anemia without evidence for blood loss can present a diagnostic challenge. Proton pump inhibitors have been associated with iron deficiency anemia for many years, yet the relationship between the two until recently was not ...
Michael Boxer
doaj   +1 more source

Real-time observation of intramolecular proton transfer in the electronic ground state of chloromalonaldehyde: An ab initio study of time-resolved photoelectron spectra [PDF]

, 2007
The authors report on studies of time-resolved photoelectron spectra of intramolecular proton transfer in the ground state of chloromalonaldehyde, employing ab initio photoionization matrix elements and effective potential surfaces of reduced ...
Arasaki, Yasuki, McKoy, Vincent, Takatsuka, Kazuo, Ushiyama, Hiroshi, Varella, Márcio T. do N., Wang, Kwanghsi   +5 more
core   +1 more source

Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report

Journal of Medical Case Reports, 2020
Background Hyponatremia is the most common electrolyte disorder. Thiazides, antidepressants, antipsychotic drugs, and antiepileptic drugs are well-known causes of hyponatremia. Proton pump inhibitor use is a rare cause of hyponatremia and, when reported,
Isabel J. B. van der Zalm, Tom J. M. Tobé, Susan J. J. Logtenberg   +2 more
doaj   +1 more source

Modified Rhodopsins From Aureobasidium pullulans Excel With Very High Proton-Transport Rates

Frontiers in Molecular Biosciences, 2021
Aureobasidium pullulans is a black fungus that can adapt to various stressful conditions like hypersaline, acidic, and alkaline environments. The genome of A. pullulans exhibits three genes coding for putative opsins ApOps1, ApOps2, and ApOps3.
Sabine Panzer, Chong Zhang, Tilen Konte, Celine Bräuer, Anne Diemar, Parathy Yogendran, Jing Yu-Strzelczyk, Georg Nagel, Shiqiang Gao, Ulrich Terpitz   +9 more
doaj   +1 more source

Photosynthesis dependent acidification of perialgal vacuoles in theParamedum bursaria/Chlorella symbiosis. Visualization by monensin [PDF]

, 1992
After treatment with the carboxylic ionophore monensin theChlorella containing perialgal vacuoles of the greenParamecium bursaria swell. TheParamecium cells remain motile at this concentration for at least one day.
A Fischer, AM Tartakoff, AM Tartakoff, B Matzke, BC Pressmann, DC Smith, E Cernichiari, E Kessler, H Kleinig, HH Mollenhauer, J Larsen, J Willenbrink, L Muscatine, MJ Geisow, N Stelly, R Sandeaux, TC Hohman, W Reisser, W Reisser, W Reisser, W Reisser, WF Boss   +21 more
core   +1 more source

Proton pump inhibitors and the risk of pneumonia: A comparison of cohort and self-controlled case series designs [PDF]

, 2013
Background: To compare the results of a new-user cohort study design and the self-controlled case series (SCCS) design using the risk of hospitalisation for pneumonia in those dispensed proton pump inhibitors compared to those unexposed as a case study ...
Australian Bureau of Statistics (ABS), C Farrington, C Farrington, C-S Eom, CP Farrington, DA Zink, Elizabeth E Roughead, Emmae N Ramsay, HJ Whitaker, HJ Whitaker, J Glanz, J Hippisley-Cox, KL Sloan, L Thomas, Nicole L Pratt, Philip Ryan, R Laheij, RJ Laheij, S Gulmez, S Suissa, S Suissa, SE Gulmez, SV Gadzhanova   +22 more
core   +1 more source

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping

International Journal of Molecular Sciences, 2023
Protein molecular machines, also known as proton pumps, are the most important element of biological membranes [...]
openaire   +2 more sources

The impact of drug-drug interactions between proton pump inhibitors and metformin: A systematic review of clinical evidence [PDF]

Pharmacia
Metformin, a substrate of the organic cation transporters, is commonly co-prescribed with proton pump inhibitors, which inhibits these transporters. However, the clinical significance of this potential drug-drug interaction remains unclear.
Ria Andani Antong, Ikhwan Yuda Kusuma, Marianti A. Manggau, Muh Akbar Bahar   +3 more
doaj   +3 more sources

Comparison of Proton Pump Inhibitor and Triple Therapy Regimen for Laryngospharyngeal Reflux Disease

Journal of Nepal Health Research Council, 2020
Background: Laryngopharyngeal reflux is retrograde flow of contents of the stomach to the larynx and the pharynx. The study aims to compare two regimens (proton pump inhibitor monotherapy versus triple therapy) on the outcome of Helicobactor pylori ...
Apar Pokharel, Jaya Prakash Mayya, Hari Prasad Upadhyay   +2 more
doaj   +1 more source